Byhealth Co., Ltd (SHE:300146)
China · Delayed Price · Currency is CNY 9.93
+0.08 (0.81%)
Oct 28, 2026, 2:05 PM CST
Byhealth Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16,634 | 20,119 | 20,306 | 28,964 | 38,801 | 45,840 | |
Market Cap Growth | -19.45% | -0.92% | -29.89% | -25.35% | -15.35% | 20.06% |
Enterprise Value | 12,604 | 15,637 | 17,760 | 26,417 | 34,272 | 43,186 |
Last Close Price | 9.85 | 11.52 | 11.20 | 14.96 | 19.88 | 22.70 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.83 | 25.72 | 31.10 | 16.59 | 28.00 | 26.14 |
Forward PE | 23.76 | 23.32 | 18.95 | 14.10 | 20.65 | 22.41 |
PS Ratio | 2.48 | 3.21 | 2.97 | 3.08 | 4.94 | 6.17 |
PB Ratio | 1.48 | 1.80 | 1.83 | 2.37 | 3.61 | 4.35 |
P/TBV Ratio | 1.73 | 2.12 | 2.16 | 2.81 | 4.41 | 5.35 |
P/FCF Ratio | 35.12 | 18.62 | 53.41 | 36.48 | 34.21 | 29.46 |
P/OCF Ratio | 27.91 | 16.58 | 29.60 | 14.12 | 28.14 | 25.20 |
PEG Ratio | - | 1.31 | 1.35 | 0.61 | 1.29 | 1.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.88 | 2.50 | 2.60 | 2.81 | 4.36 | 5.81 |
EV/EBITDA Ratio | 11.68 | 13.52 | 18.02 | 12.75 | 19.33 | 21.47 |
EV/EBIT Ratio | 15.91 | 17.54 | 23.87 | 14.31 | 21.96 | 24.04 |
EV/FCF Ratio | 26.55 | 14.47 | 46.71 | 33.27 | 30.22 | 27.76 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.11 | 0.09 | 0.14 | 0.01 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 1.11 | 0.89 | 1.53 | 0.08 | 0.01 | 0.04 |
Debt / FCF Ratio | 2.52 | 0.96 | 4.06 | 0.22 | 0.02 | 0.05 |
Net Debt / Equity Ratio | -0.37 | -0.47 | -0.44 | -0.51 | -0.52 | -0.55 |
Net Debt / EBITDA Ratio | -3.84 | -4.59 | -4.91 | -3.02 | -3.16 | -2.90 |
Net Debt / FCF Ratio | -8.72 | -4.91 | -12.72 | -7.89 | -4.94 | -3.75 |
Asset Turnover | 0.48 | 0.44 | 0.47 | 0.67 | 0.60 | 0.66 |
Inventory Turnover | 3.04 | 3.13 | 2.91 | 3.11 | 2.89 | 2.98 |
Quick Ratio | 2.50 | 2.61 | 2.22 | 2.76 | 2.85 | 3.03 |
Current Ratio | 3.18 | 2.95 | 2.55 | 3.38 | 3.44 | 3.54 |
Return on Equity (ROE) | 6.20% | 7.33% | 5.55% | 15.47% | 13.26% | 20.21% |
Return on Assets (ROA) | 3.54% | 3.94% | 3.17% | 8.17% | 7.47% | 9.93% |
Return on Invested Capital (ROIC) | 9.57% | 11.89% | 8.75% | 26.88% | 26.22% | 34.52% |
Return on Capital Employed (ROCE) | 6.90% | 7.80% | 6.60% | 14.60% | 14.10% | 16.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.20% | 3.89% | 3.21% | 6.03% | 3.57% | 3.83% |
FCF Yield | 2.85% | 5.37% | 1.87% | 2.74% | 2.92% | 3.39% |
Dividend Yield | 4.53% | 3.75% | 2.99% | 5.29% | 0.79% | 2.60% |
Payout Ratio | 109.96% | 77.59% | 232.31% | 17.53% | 85.89% | 63.50% |
Buyback Yield / Dilution | 4.32% | 3.13% | -1.33% | 0.91% | -2.42% | -5.21% |
Total Shareholder Return | 8.88% | 6.88% | 1.66% | 6.19% | -1.63% | -2.61% |